| Sample | Title | Value | Rank |
|---|
| GSM303966 | SLE-7 #4 @12wks, asymptomatic (-2077090517) | 178.829 | 83 |
| GSM303972 | SLE-7 #3 @12wks, asymptomatic (-2077090523) | 190.258 | 84 |
| GSM303986 | SLE-7 #2 @12wks, asymptomatic (-2077090529) | 174.549 | 82 |
| GSM303991 | SLE-7 #1 @12wks, asymptomatic (-2077090535) | 237.475 | 87 |
| GSM303961 | SLE-7 #1 @36wks, asymptomatic on treatment with sirolimus (-2101366109) | 179.231 | 83 |
| GSM303979 | SLE-7 #3 @36wks, asymptomatic on treatment with sirolimus (-2101365196) | 142.175 | 78 |
| GSM303985 | SLE-7 #2 @36wks, asymptomatic on treatment with sirolimus (-2101365652) | 147.086 | 79 |
| GSM303971 | SLE-7 #2 @36wks, diseased/symptomatic (-2101366115) | 797.767 | 97 |
| GSM303973 | SLE-7 #1 @36wks, diseased/symptomatic (-2101366147) | 269.639 | 89 |
| GSM303980 | SLE-7 #3 @36wks, diseased/symptomatic (-2102085829) | 374.843 | 93 |
| GSM303962 | SLE-7 #3 @42wks, asymptomatic on treatment with sirolimus (-2101365164) | 126.207 | 76 |
| GSM303978 | SLE-7 #2 @42wks, asymptomatic on treatment with sirolimus (-2102085846) | 166.226 | 82 |
| GSM303982 | SLE-7 #1 @42wks, asymptomatic on treatment with sirolimus (-2101365170) | 161.488 | 81 |
| GSM303965 | SLE-7 #2 @42wks, diseased/symptomatic (-2102085823) | 233.478 | 87 |
| GSM303968 | SLE-7 #1 @42wks, diseased/symptomatic (-2101365185) | 282.329 | 90 |
| GSM303981 | SLE-7 #3 @42wks, diseased/symptomatic (-2101365176) | 314.247 | 91 |